NO EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF SERELAXIN, A RECOMBINANT HUMAN RELAXIN-2 IN DEVELOPMENT FOR THE TREATMENT OF ACUTE HEART FAILURE Article Kobalava Z., Halabi A., Zahringer A., Pang Y., Dahlke M. Circulation. Lippincott Williams & Wilkins. Vol. 128. 2013.
EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C WITH PEG-IFN ALPHA-2B AND RIBAVIRIN IN COMBINATION WITH METFORMIN IN PATIENTS WITH HCV-1 GENOTYPE AND INSULIN RESISTANCE Article Khafisova O.O., Tarasova O., Mazurchik N., Ogurtsov P.P. HEPATOLOGY. WILEY-BLACKWELL. Vol. 58. 2013.